A Study to Assess the Safety and Efficacy of Probiotic to Modulate Psychological Stress

NCT04125810 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2020-03-25

No results posted yet for this study

Summary

The purpose of this clinical trial is to determine whether Probiotic can modulate the psychological stress experienced by healthy medical, dental and health science students preparing for university/institute of technology semester examination (s), measured by self-report scales and hypothalamic pituitary adrenal axis activity, compared with placebo.

Conditions

  • Stress, Psychological
  • Healthy

Interventions

BIOLOGICAL

Probiotic

Probiotic

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • ICON plc

    collaborator INDUSTRY
  • Daacro

    collaborator NETWORK
  • 4Pharma Ltd.

    collaborator INDUSTRY
  • Danisco

    lead INDUSTRY

Principal Investigators

  • Balgit Chhokar · Medinova East London Dedicated Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2020-02-07
Completion
2020-02-07

Countries

  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04125810 on ClinicalTrials.gov